The intricacies of the collusion and parties involved are not easily identifiable by design. For one, we don't know the whole motive behind it. Is it solely for financial gain by the organized cabal? Might BP be secretly behind it, funding the effort to keep the price low for buyout purposes or in some cases (not this) to destroy a threat? Spending $millions in order to save $billions is a good business strategy, albeit criminal. Sounds unfathomable to some, but we're talking big business, big money. Look how BP "influences" our government agencies and media. How else does one explain the holding of 15M short shares while price is ascending and approval imminent, unless most are hedged with Call options... or worse, phantom shares due to naked shorting and FTDs? There's also no need to cover if you know there's going to be another short attack...
I look at other biotechs with very promising therapies, a couple that have delivered excellent P3 results, along with peer-reviewed journals (one had 70 expert doctor authors) and still the price is attacked and naked-shorted down extremely low, under the cover of another Fraudstein lying hit piece.
Good to see these companies fighting back with lawsuits, using some powerful attorneys. We'll see what comes from it and if anyone does jail time. SEC does little to try to stop it... perhaps compromised.